Dean Investment Associates’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Other funds holding PBH
AI
VPM
VCM
Dean Investment Associates's PBH Position: Q1 2026 in Review
Dean Investment Associates increased its Prestige Consumer Healthcare (PBH) stake by 61% in Q1 2026, buying an estimated $2.37M and bringing the position to 96,630 shares worth $5.73M. The position accounts for 0.81% of the portfolio, ranked #31.
Dean Investment Associates first reported a position in PBH in Q4 2020 and has held it in 18 quarters since. The position peaked at $6.67M in Q1 2024. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.
- Dean Investment Associates held 96,630 shares of Prestige Consumer Healthcare worth $5.73M as of Q1 2026.
- Dean Investment Associates bought 36,499 Prestige Consumer Healthcare shares in Q1 2026, an estimated $2.37M.
- Prestige Consumer Healthcare made up 0.81% of Dean Investment Associates's portfolio in Q1 2026, its #31 holding.
- Dean Investment Associates first reported a position in Prestige Consumer Healthcare in Q4 2020 and has held it in 18 quarters since.
- Dean Investment Associates's Prestige Consumer Healthcare position peaked at $6.67M in Q1 2024.
- 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.
Based on Dean Investment Associates's 13F filing for Q1 2026, filed 15 May 2026.